Absence of JAK2-V617F in paroxysmal nocturnal haemoglobinuria-associated thrombosis

被引：7
作者：
Fouassier, Marc [1 ]
Girodon, Francois [2 ]
Cleyrat, Cedric [3 ]
Robillard, Nelly
Garand, Richard
Hermouet, Sylvie [3 ]
机构：
[1] CHU Nantes, Hematol Lab, Inst Biol, F-44093 Nantes, France
[2] CHU Dijon, Hematol Lab, Dijon, France
[3] CHU Nantes, INSERM, UMR 892, Inst Biol, F-44035 Nantes 01, France
来源：
THROMBOSIS AND HAEMOSTASIS | 2009年 / 102卷 / 01期
关键词：
LATENT MYELOPROLIFERATIVE DISORDER; VEIN-THROMBOSIS; ESSENTIAL THROMBOCYTHEMIA; MYELODYSPLASTIC SYNDROMES; V617F MUTATION; JAK2; V617F; DIAGNOSIS; CLONES; DEFICIENT; ANEMIA;
D O I：
10.1160/TH09-03-0140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：180 / 182
页数：3
相关论文
共 26 条
[1]   Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis [J].
Boissinot, Marjorie ;
Lippert, Eric ;
Girodon, Francois ;
Dobo, Irene ;
Fouassier, Marc ;
Masliah, Claude ;
Praloran, Vincent ;
Hermouet, Sylvie .
BLOOD, 2006, 108 (09) :3223-3224
[2]   The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS) [J].
Boissinot, Marjorie ;
Garand, Richard ;
Hamidou, Mohamed ;
Hermouet, Sylvie .
BLOOD, 2006, 108 (05) :1781-1782
[3]   Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria [J].
Brodsky, Robert A. .
BLOOD REVIEWS, 2008, 22 (02) :65-74
[4]   The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia [J].
Cheung, B ;
Radia, D ;
Pantelidis, P ;
Yadegarfar, G ;
Harrison, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (02) :244-245
[5]   Paroxysmal nocturnal hemoglobinuria:: natural history of disease subcategories [J].
de Latour, Regis Peffault ;
Mary, Jean Yves ;
Salanoubat, Celia ;
Terriou, Louis ;
Etienne, Gabriel ;
Mohty, Mohamad ;
Roth, Sophie ;
de Guibert, Sophie ;
Maury, Sebastien ;
Cahn, Jean Yves ;
Socie, Gerard .
BLOOD, 2008, 112 (08) :3099-3106
[6]   Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status [J].
Finazzi, Guido ;
Rambaldi, Alessandro ;
Guerini, Vittoria ;
Carobbo, Alessandra ;
Barbui, Tiziano .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01) :135-136
[7]   Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia [J].
Hugel, B ;
Socié, G ;
Vu, T ;
Toti, F ;
Gluckman, E ;
Freyssinet, JM ;
Scrobohaci, ML .
BLOOD, 1999, 93 (10) :3451-3456
[8]   The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases [J].
Kiladjian, Jean-Jacques ;
Cervantes, Francisco ;
Leebeek, Franck W. G. ;
Marzac, Christophe ;
Cassinat, Bruno ;
Chevret, Sylvie ;
Cazals-Hatem, Dominique ;
Plessier, Aurelie ;
Garcia-Pagan, Juan-Carlos ;
Murad, Sarwa Darwish ;
Raffa, Sebastian ;
Janssen, Harry L. A. ;
Gardin, Claude ;
Cereja, Sophie ;
Tonetti, Carole ;
Giraudier, Stephane ;
Condat, Bertrand ;
Casadevall, Nicole ;
Fenaux, Pierre ;
Valla, Dominique C. .
BLOOD, 2008, 111 (10) :4922-4929
[9]   Genetic complexity of myeloproliferative neoplasms [J].
Kralovics, R. .
LEUKEMIA, 2008, 22 (10) :1841-1848
[10]   Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2 [J].
Kralovics, R ;
Teo, SS ;
Buser, AS ;
Brutsche, M ;
Tiedt, R ;
Tichelli, A ;
Passamonti, F ;
Pietra, D ;
Cazzola, M ;
Skoda, RC .
BLOOD, 2005, 106 (10) :3374-3376
123